INC Research/inVentiv now Syneos Health

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/manaemedia)
(Image: iStock/manaemedia)

Related tags: Management occupations

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

The company​, with a combined staff of more than 21,000 employees across more than 60 counties, will now be known as Syneos Health, Inc., effective January 4, 2018.

Syneos Health common shares will trade on the Nasdaq Global Select Market under the new ticker symbol “SYNH” by January 9, 2018.

"Since close, we’ve quickly assembled an Integrated Solutions Group, bringing together seasoned industry product strategists with regulatory, clinical, commercial and real world expertise​," Alistair Macdonald, CEO of Syneos Health told Outsourcing-Pharma.com.

"This group is working with customers across the small to mid to large continuum to determine the right mix of clinical and commercial capabilities to produce a higher likelihood of launch success,​” he added. 

Also this week, the company announced that Greg Rush is stepping down as chief financial officer (CFO) to pursue a different opportunity. The company has initiated the search for a replacement.

The current executive vice president and CFO of the company’s commercial solutions business will be appointed as interim CFO at the end of April if a replacement has not been found, according to the company.

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more